"HCA Houston Healthcare Clear Lake is a 532-bed, full-service hospital offering inpatient and outpatient medical services to Houston’s Bay Area since 1972. We provide advanced cardiovascular care, orthopedics, neurological care, emergency medicine, pediatrics, and comprehensive women’s services including high-risk obstetrical care. Our campus includes a Level II trauma center, neuroscience institute, dedicated heart hospital, Level III neonatal ICU, pediatric emergency department and the area’s only pediatric ICU. As a part of one of the largest healthcare systems in Houston, HCA Houston Healthcare, we are committed to providing accessible, patient-centered care in the communities we serve. For more information, please visit our website."

During the past decade, Clear Lake Regional Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clear Lake Regional Medical Center" #1 sponsor was "Harvard Pilgrim Health Care" with 6 trials, followed by "Acerta Pharma BV" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "The University of Texas Health Science Center, Houston" with 1 trials sponsored and "University of California, Irvine" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clear Lake Regional Medical Center" #1 collaborator was "University of California, Irvine" with 6 trials as a collaborator, "University of Massachusetts, Amherst" with 6 trials as a collaborator, "Brigham and Women's Hospital" with 5 trials as a collaborator, "Centers for Disease Control and Prevention" with 5 trials as a collaborator and "Rush University" with 5 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Clear Lake Regional Medical Center" are "Abdominal (ABD) Infection" (1 trials), "Cluster Detection" (1 trials), "Coronary Artery Disease" (1 trials), "Healthcare Associated Infections" (1 trials) and "Ischemic Stroke" (1 trials). Many other conditions were trialed in "Clear Lake Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Clear Lake Regional Medical Center" are "Other" (5 trials), "Drug" (4 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arm 1: Routine Care" (2 trials), "INSPIRE CPOE Smart Prompt" (2 trials), "Routine Care" (2 trials), "Arm 1. Routine Care (Mupirocin/CHG)" (1 trials) and "Arm 2. Iodophor/CHG Decolonization" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clear Lake Regional Medical Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Clear Lake Regional Medical Center". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Clear Lake Regional Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clear Lake Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".